| Application no. and date | 13835291.9 (espacenet) (Federated) (European Patent Register), 20130906 | | Patent/reg. no. and date | DK/EP 2892550, 20191218 | | Publication date | 20150715 | | Priority no. and date | US 201261698138 P, 20120907, US 201361769581 P, 20130226, US 201361770421 P, 20130228 | | EP pub. no. and date |
EP 2892550 20150715 | | Effective date | | | Applicant/owner | Coherus Biosciences, Inc., 201 Redwood Shores Parkway Suite 200
Redwood City, CA 94065, US | | Applicant ref. no. | 1528294 | | Inventor | MANNING, Mark, 4630 Sorrel Lane
Johnstown, CO 80534, US,
PAYNE, Robert W., 221 Cleopatra Street
Fort Collins, CO 80525, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) | | Title | STABILE VANDIGE FORMULERINGER AF ADALIMUMAB | | Int. application no. | US2013058618 | | Int. publication no. | WO2014039903 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
